AHK-Cu 50mg Peptide

In cellular bioenergetics and hair follicle biology research, specialized copper complex peptides are widely evaluated for their role in follicular proliferation and extracellular matrix synthesis. The ahk cu copper tripeptide complex represents a targeted copper-binding peptide engineered to evaluate dermal papilla cell growth and skin tissue health in controlled laboratory environments.

By delivering bioavailable copper directly to dermal cells, the peptide ahk cu sequence provides researchers with a refined molecular tool to study cellular signaling, microvascular development around hair follicles, and collagen production.

Technical Specifications & Product Details

Attribute	Specification Details
Form	Lyophilized (freeze-dried) powder
Vial Capacity	50mg total mass
Sequence / Class	Ala-His-Lys-Cu (Amino acid copper complex)
Purity Standard	\ge 98\% purity standard
Physical Appearance	Solid cake with a characteristic light blue tint

Research Context & Scientific Applications

What is AHK-Cu?

When researchers examine what is ahk cu, literature defines it as Ala-His-Lys Copper Tripeptide-1. It is a synthetic tripeptide consisting of alanine, histidine, and lysine complexed with a copper (II) ion. This specific amino acid sequence exhibits high affinity for hair follicle dermal papilla cells, where it regulates apoptotic pathways and stimulates cell proliferation.

GHK-Cu vs AHK-Cu: Comparative Research Analysis

Both GHK-Cu and AHK-Cu are copper-binding tripeptides, yet scientific literature distinguishes their primary physiological targets:

• AHK-Cu (Ala-His-Lys-Cu): Demonstrates superior specificity for dermal papilla cells and hair follicle elongation. Research indicates it upregulates vascular endothelial growth factor (VEGF) to support microcirculation around hair roots while preventing premature follicle regression.
• GHK-Cu (Gly-His-Lys-Cu): Focuses predominantly on systemic skin remodeling, wound healing, collagen I and III synthesis, and general anti-inflammatory activity throughout the dermal matrix.

Understanding the difference in ghk cu vs ahk cu enables research teams to select the optimal peptide depending on whether the primary trial objective is hair follicle biology or broad dermal wound healing.

Topical & Experimental Formulations

In non-clinical topical research models, investigators often incorporate reconstituted AHK-Cu into specialized vehicle solutions. Discussions regarding an ahk cu hair serum recipe or an experimental ahk cu serum focus on maintaining optimal pH levels (typically 5.5 to 6.5) and avoiding strong oxidizing or acidic ingredients that could detach the copper ion from the peptide chain.

Note on Research Vectors: While preclinical studies investigate both topical applications and ahk cu injection protocols in animal models, standardized liquid vehicles are strictly formulated to maintain complex stability across variable assay environments.

Commonly Matched Compounds

In multi-pathway follicular and skin research designs, AHK-Cu is frequently paired with complementary research agents, including:

• GHK-Cu: Combined to evaluate dual hair follicle stimulation and scalp skin remodeling.
• BPC-157: Paired in tissue injury models to evaluate microvascular repair alongside cellular proliferation.
• Biotinoyl Tripeptide-1: Studied together in topical models to evaluate hair anchoring and structural protein expression.

Compliance Notice: AHK-Cu 50mg is designated strictly for laboratory research, in vitro testing, and non-clinical scientific evaluation. It is not approved for human consumption, direct medical treatment, or clinical diagnostic use.

Dosing & Protocol Guidelines

Peptide Handling Reference

Copper tripeptides are sensitive to drastic pH shifts, ultraviolet light, thermal fluctuations, and strong chelating agents. Exposure to acidic conditions can cause copper ions to dissociate from the amino acid backbone, rendering the compound ineffective. Handle containers with care.

Reconstitution Protocol

To reconstitute a 50mg vial of AHK-Cu in a laboratory setting, follow this standardized sequence:

1. Thermal Equalization
   Prerequisite
   Remove the lyophilized 50mg vial from cold storage. Let the container rest at room temperature for 15 to 20 minutes prior to adding diluent to avoid thermal shock.
2. Slow Solvent Introduction
   Dilution
   Sanitize the rubber stopper with an alcohol wipe. Using a sterile syringe, slowly introduce bacteriostatic water down the interior glass wall of the vial. Avoid spraying the solvent directly onto the powder cake.
3. Gentle Swirling
   Dissolution
   Do not shake the vial. Gently roll the vial between your palms or swirl it smoothly in circles until the powder dissolves into a clear, light blue liquid.

Storage Requirements

• Unreconstituted Powder: Store long-term in a laboratory freezer at -20^\circ\text{C}, protected from light exposure, to maintain stability for up to 24 months.
• Reconstituted Liquid Solution: Store continuously in a laboratory refrigeration unit at 2^\circ\text{C} to 8^\circ\text{C}. Protect from direct light. For optimal experimental accuracy, utilize liquid solutions within 28 days of preparation.

Side Effects & Safety Observations

Safety Observations

Data drawn from preclinical and cellular models indicate a favorable safety profile:

• Localized Tolerance: Mild, transient surface redness or irritation may occur at application or administration sites in animal models.
• Cellular Toxicity: Low cytotoxic potential observed in dermal papilla cell cultures when maintained within standard micromolar concentration ranges.
• Copper Accumulation: Soluble peptide complexes are processed through standard cellular turnover pathways without evidence of systemic copper accumulation at baseline research dosages.

Contraindications

Research protocols incorporating AHK-Cu should exclude experimental setups displaying:

• Known hypersensitivity to copper-containing compounds or synthetic peptides.
• Co-application with strong acids (such as L-ascorbic acid or alpha hydroxy acids) in liquid assays, which denature the peptide structure.
• Pregnancy or lactation models due to an absence of safety data regarding embryonic exposure.

Interaction Review

Mixing AHK-Cu directly in solution with strong chelating agents (such as EDTA) or ascorbic acid will strip the bound copper ion from the tripeptide. Always test compatibility in small assay volumes before combining AHK-Cu with other active compounds in a single vehicle.

COA & Testing Integrity

Certificate of Analysis (COA)

To guarantee experimental accuracy and batch consistency, every lot of AHK-Cu 50mg must undergo analytical verification by an independent, third-party laboratory. A compliant COA verifies:

1. Mass Spectrometry (MS): Confirms the exact molecular weight and amino acid sequence (Ala-His-Lys) complexed with copper.
2. High-Performance Liquid Chromatography (HPLC): Measures the absolute purity level of the batch, ensuring it meets or exceeds the required 98% purity standard without chemical synthesis contaminants.

Quality Inspection Checklist

Prior to introducing a new batch into an active research protocol, complete the following quality checks:

• The protective seal is intact and shows no signs of physical tampering.
• Third-party MS and HPLC reports correspond directly to the lot number on the vial.
• The lyophilized cake is dry, uniform, and displays a uniform light blue color.
• Post-reconstitution solution appears transparent light blue and free from cloudiness or suspended particles.